Last reviewed · How we verify
Post-Closure Local Anesthetic
At a glance
| Generic name | Post-Closure Local Anesthetic |
|---|---|
| Also known as | Bupivicaine |
| Sponsor | Valley Anesthesiology Consultants |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Radiographic and Histological Assessment of GBR Using DBB Compared to Spontaneous Bone Regeneration of Maxillary Defects , Resulted From Enucleation of Intra-bony Cystic Lesions (NA)
- Efficacy and Safety of Myopic Macular Hole Closure Surgery Without Endotamponade Agent (NA)
- Perioperative Multimodal Analgesia for Supratentorial Craniotomy (NA)
- Vaginal Cuff Bupivacaine Injection for Postoperative Pain (NA)
- General Anesthesia Versus Sedation By Dexmedetomidine and Ketamine With Local Infiltration for Percutaneous Transcatheter Closure of Atrial Septal Defect in Pediatric Patients (NA)
- Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery (PHASE3)
- The Effect of Local Anesthesia Techniques on Postoperative Pain After Laser Treatment of Pilonidal Sinus (NA)
- Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Post-Closure Local Anesthetic CI brief — competitive landscape report
- Post-Closure Local Anesthetic updates RSS · CI watch RSS
- Valley Anesthesiology Consultants portfolio CI